FDA Inspection 1086615 — Aparna Pharmaceuticals Private Limited
The FDA completed an inspection of Aparna Pharmaceuticals Private Limited on Mar 15, 2019 in Pyidibhimavaram, Srikakulam. The inspection was classified OAI (Official Action Indicated — regulatory and/or administrative actions are recommended). Product area: Drugs.
Inspection Details
- Classification
- Official Action Indicated (OAI)
- End Date
- Mar 15, 2019
- Fiscal Year
- 2019
- Product Type
- Drugs
- Project Area
- Drug Quality Assurance
- Location
- Pyidibhimavaram, Srikakulam (India)